Pharmaceutical composition for preventing or treating of systemic inflammatory disease comprising diketopiperazine as an active ingredient
KR20170089334A
Method for diagnosing microcirculation inflammation or antibody-mediated rejection in kidney transplant recipients using the frequency of HLA-DR+ T cells in peripheral blood
KR20170089309A
Method for diagnosing kidney allograft rejection using the frequency of CD4+CD25+ T cells in peripheral blood
KR20170071996A
Pharmaceutical composition of the prevention or treatment of allergic diseases comprising pdks inhibitor as an effective component
KR20170047004A
Compositions for preventing or treating vascular inflammatory diseases comprising exendin-4 analogues PEGylated with polyethylene glycol derivatives
KR101681041B1
A noble aromatic compound derivatives as a ligand to inactivate err gamma
KR20160132534A
Pharmaceutical composition for prevention or treatment of cancer comprising ror activating regulator
US2015196604A1
Agent for Treating Urinary Incontinence Including Stem Cells Derived from Amniotic Fluid
KR20160062517A
A pharmaceutical composition for inhibition of vascular calcification comprising dpp-4 inhibitor as an effective component
KR20160046343A
A marker for predicting the risks of developing lung cancer among never-smoker and a method for predicting the risks of developing lung cancer using the same
KR20160043419A
Errγ as the biomaker to liver cancer and use thereof
WO2015141875A1
Smad protein activator and pharmaceutical composition containing same
WO2015141874A1
Pharmaceutical composition for preventing or treating vascular disease containing gemigliptin as active ingredient
KR20150106196A
A pharmaceutical composition for prevention or treatment of diabetes comprising n-(2-hydroxyethyl)-3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide or pharmaceutically acceptable salts thereof as an effective component
KR20150078123A
The composition of cryo-medium for cryopreservation of human amniotic fluid-derived stem cell
KR20130109078A
A freezing medium composition for cryopreserving amniotic fluid-derived stem cells and a method for cryopreserving the same
KR20150029802A
A pharmaceutical composition for prevention or treatment of diabetes comprising 3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide or pharmaceutically acceptable salts thereof as an effective component
KR20140134579A
Pharmaceutical composition for prevention and treatment of obesity and fatty liver comprising mineral extract of deep sea water
KR20140134580A
Pharmaceutical composition for prevention and treatment of hyperglycemia and type 2 diabetes comprising mineral extract of deep sea water
KR101334265B1
A diagnostic composition for polypoidal choroidal vasculopathy
